Mesenchymal stem cell transplantation: A potential therapy for oral lichen planus

Medical Hypotheses

Volumn 76, Issue 3, 2011, Pages 322-324

  Ding, Gang ^a,b   Wang, Wei ^a   Liu, Yi ^a   Zhang, Chunmei ^a   Wang, Songlin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN G;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; LICHEN PLANUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MOUTH LICHEN PLANUS; NONHUMAN; SYSTEMIC THERAPY;

AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; HUMANS; LICHEN PLANUS, ORAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; STEM CELLS; WOUND HEALING;

EID: 79751537724     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.09.025     Document Type: Article

References (34)

1. Sugerman P.B., Savage N.W., Walsh L.J., Seymour G.J. Disease mechanisms in oral lichen planus: a possible role for autoimmunity. Aust J Dermatol 1993, 34:63-69.
2. Sugerman P.B., Savage N.W., Walsh L.J., et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002, 13:350-365.
3. Khan A., Farah C.S., Savage N.W., Walsh L.J., Harbrow D.J., Sugerman P.B. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003, 32:77-83.
4. Gándara Rey J., García García A., Blanco Carrión A., Gándara Vila P., Rodríguez Nuñez I. Cellular immune alterations in fifty-two patients with oral lichen planus. Med Oral 2001, 6:246-262.
5. Hasséus B., Jontell M., Brune M., Johansson P., Dahlgren U.I. Langerhans cells and T cells in oral graft versus host disease and oral lichen planus. Scand J Immunol 2001, 54:516-524.
6. Iijima W., Ohtani H., Nakayama T., et al. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP - 10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. Am J Pathol 2003, 163:261-268.
7. Chou M.J., Daniels T.E. Langerhans cells expressing HLA-DQ, HLA-DR and T6 antigens in normal oral mucosa and lichen planus. J Oral Pathol Med 1989, 18:573-576.
8. Villarroel Dorrego M., Correnti M., Delgado R., Tapia F.J. Oral lichen planus: immunohistology of mucosal lesions. J Oral Pathol Med 2002, 31:410-414.
9. Simark-Mattsson C., Bergenholtz G., Jontell M., et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol 1999, 44:499-507.
10. Hiroki A., Nakamura S., Shinohara M., Oka M. Significance of oral examination in chronic graft-versus-host disease. J Oral Pathol Med 1994, 23:209-215.
11. Zhao Z.Z., Sugerman P.B., Zhou X.J., Walsh L.J., Savage N.W. Mast cell degranulation and the role of T cell RANTES in oral lichen planus. Oral Dis 2001, 7:246-251.
12. Friedenstein A.J., Gorskaja U., Kalugina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976, 4:267-274.
13. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
14. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000, 28:875-884.
15. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
16. Angoulvant D., Clerc A., Benchalal S., et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology 2004, 41:469-476.
17. Fibbe W.E., Noort W.A. Mesenchymal stem cells and hematopoietic stem cells transplantation. Ann NY Acad Sci 2003, 996:235-244.
18. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
19. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30:42-48.
20. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003, 57:11-20.
21. Djouad F., Plence P., Bony C., et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003, 102:3837-3844.
22. Krampera M., Glennie S., Dyson J., et al. Bone marrow mesenchymal stem cells inhibit the response of naïve and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
23. Maitra B., Szekely E., Gjini K., et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004, 33:597-604.
24. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
25. Maccario R., Podestà M., Moretta A., et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune responses favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005, 90:516-525.
26. Corcione A., Benvenuto F., Ferretti E., et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006, 107:367-372.
27. Rasmusson I., Le Blanc K., Sundberg B., Ringdén O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 2007, 65:336-343.
28. Deng W., Han Q., Liao L., You S., Deng H., Zhao R.C. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 2005, 24:458-463.
29. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cell. Lancet 2004, 363:1439-1441.
30. Ringdén O., Uzunel M., Rasmusson I., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006, 81:1390-1397.
31. Le Blanc K., Frassoni F., Ball L.M. Mesenchymal stem cells for treatment of severe acute graft-versus-host disease [abstract]. Blood 2006, 108:753.
32. Fouillard L., Bensidhoum M., Bories D., et al. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 2003, 17:474-476.
33. Lee S.T., Jang J.H., Cheong J.W., et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 2002, 118:1128-1131.
34. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005, 11:389-398.